Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-25-009643
Filing Date
2025-08-14
Accepted
2025-08-14 16:11:45
Documents
62
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q endra_10q.htm   iXBRL 10-Q 833126
2 CERTIFICATION endra_ex311.htm EX-31.1 13470
3 CERTIFICATION endra_ex312.htm EX-31.2 14631
4 CERTIFICATION endra_ex321.htm EX-32.1 4303
  Complete submission text file 0001654954-25-009643.txt   4015300

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA endra-20250630.xsd EX-101.SCH 48016
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE endra-20250630_lab.xml EX-101.LAB 269683
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE endra-20250630_cal.xml EX-101.CAL 40777
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE endra-20250630_pre.xml EX-101.PRE 225956
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE endra-20250630_def.xml EX-101.DEF 124625
65 EXTRACTED XBRL INSTANCE DOCUMENT endra_10q_htm.xml XML 532895
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37969 | Film No.: 251219136
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)